Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Feb. 02, 2013
Jan. 28, 2012
Jan. 29, 2011
OPERATING ACTIVITIES:      
Net loss $ (27,676,000) $ (48,064,000) $ (25,868,000)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:      
Depreciation and amortization 13,424,000 12,827,000 13,337,000
Share-based compensation 3,257,000 5,007,000 3,350,000
Write-off of deferred financing costs 2,306,000 0 0
Amortization of deferred revenue (87,000) (1,061,000) (728,000)
Amortization of debt discount 0 575,000 2,121,000
Amortization of deferred finance costs 249,000 609,000 305,000
Asset impairments and write-offs 11,111,000 0 809,000
Debt extinguishment 500,000 25,679,000 1,235,000
Gain on the disposal of equipment (102,000) (416,000) 0
Changes in operating assets and liabilities:      
Accounts receivable, net (18,086,000) 9,909,000 (21,292,000)
Inventories, net 6,321,000 (3,676,000) 4,277,000
Prepaid expenses and other (2,066,000) (460,000) 348,000
Deferred Revenue 0 500,000 0
Accounts payable and accrued liabilities 2,367,000 (15,447,000) 16,768,000
Accrued dividends payable — Series B Preferred Stock 0 1,069,000 5,665,000
Net cash provided by (used for) operating activities (8,482,000) (12,949,000) 327,000
INVESTING ACTIVITIES:      
Property and equipment additions (6,157,000) (11,096,000) (7,584,000)
Change in restricted cash and investments 0 2,861,000 99,000
Purchase of NBC Trademark License (4,000,000) 0 0
Proceeds from disposal of equipment 102,000 416,000 55,000
Net cash used for investing activities (10,055,000) (7,819,000) (7,430,000)
FINANCING ACTIVITIES:      
Payment for Series B Preferred stock redemption 0 (40,853,000) 0
Payment for Series B Preferred stock dividend 0 (8,915,000) (2,500,000)
Payments for deferred issuance costs (552,000) (306,000) (3,292,000)
Proceeds from Issuance of Long-term Debt 38,215,000 0 0
Repayments of Long-term Debt (25,715,000) 0 0
Proceeds from exercise of stock options 109,000 1,828,000 357,000
Proceeds from issuance of term loan 0 0 25,000,000
Procceeds from issuance of common stock, net 0 55,500,000 17,009,000
Net cash provided by (used for) financing activities 12,057,000 7,254,000 36,574,000
Net increase (decrease) in cash and cash equivalents (6,480,000) (13,514,000) 29,471,000
BEGINNING CASH AND CASH EQUIVALENTS 32,957,000 46,471,000 17,000,000
ENDING CASH AND CASH EQUIVALENTS $ 26,477,000 $ 32,957,000 $ 46,471,000